ETB

Energy Toolbase Launches ETB Monitor, a Software Platform for Monitoring the Performance and Savings of Solar and Energy Storage Projects

Retrieved on: 
Wednesday, October 27, 2021
Acumen, Industry, C&I, Toronto Stock Exchange, ETB, Utility, SOC, VP, Software, PSI, Control, UI, ESS, Renewable energy, Cryptocurrency

STUART, Fla., Oct. 27, 2021 /PRNewswire/ --Energy Toolbase has announced the launch of ETB Monitor , a software monitoring platform that provides real-time insights into the performance and savings of solar + energy storage systems (ESS) operating in the field.

Key Points: 
  • STUART, Fla., Oct. 27, 2021 /PRNewswire/ --Energy Toolbase has announced the launch of ETB Monitor , a software monitoring platform that provides real-time insights into the performance and savings of solar + energy storage systems (ESS) operating in the field.
  • Energy Toolbase's "Model, Control, Monitor" product lineup provides a cohesive suite of software tools for project developers to deploy solar + storage projects more efficiently.
  • Since 2014, the ETB Developer product has specialized in performing accurate, objective, and transparent utility rate and avoided cost analysis of solar + storage projects.
  • Energy Toolbase is an industry-leading software platform that provides a cohesive suite of project estimating, storage control, and asset monitoring products that enable solar and storage developers to deploy projects more efficiently.

Molecular Templates to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Retrieved on: 
Monday, September 20, 2021
GLOBE, Cancer, Therapy, Nasdaq, ETB, Pharmaceutical industry, Machine tool, Fine chemical

AUSTIN, Texas, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, will present and participate in 1-on-1 investor meetings at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit , to take place September 20-23, 2021.

Key Points: 
  • AUSTIN, Texas, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, will present and participate in 1-on-1 investor meetings at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit , to take place September 20-23, 2021.
  • Presentation details can be found below:

Quest Diagnostics Updates Outlook For Full Year 2021

Retrieved on: 
Thursday, September 9, 2021

As used in this press release the term "reported" refers to measures under accounting principles generally accepted in the United States ("GAAP").

Key Points: 
  • As used in this press release the term "reported" refers to measures under accounting principles generally accepted in the United States ("GAAP").
  • Quest Diagnostics empowers people to take action to improve health outcomes.
  • The outlook for adjusted diluted EPS represents management's estimates for the full year 2021 before the impact of special items.
  • The following table reconciles our full year 2021 outlook for adjusted diluted EPS to the corresponding amounts determined under GAAP:

Molecular Templates, Inc. Reports Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, August 12, 2021
Biology, Coley's toxins, Forward-looking statement, Doctor of Philosophy, Pharmacodynamics, Bristol Myers Squibb, Index (publishing), Private Securities Litigation Reform Act, Tumor microenvironment, Multiple myeloma, American Association, Patient, COVID-19, TIGIT, American Association for Cancer Research, NK, IND, GLOBE, Chief scientific officer, SEC, Research, Cell, Vertex, Conference, EC50, Investment, Breast cancer, PD-L1, CD20, ETB, MTD, PD, CD45, Association, Neoplasm, Cancer, Nasdaq, Safety, AACR, Therapy, Ladenburg, ETB (company), Vaccine, Animal, Iron ore, Gasoline, Pharmaceutical industry, Risk management

AUSTIN, Texas, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, Molecular Templates, or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today reported financial results for the second quarter of 2021.

Key Points: 
  • AUSTIN, Texas, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, Molecular Templates, or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today reported financial results for the second quarter of 2021.
  • MTEM provided a corporate update and participated in 1-on-1 investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference, which took place July 13-14, 2021.
  • The net loss attributable to common shareholders for the second quarter of 2021 was $15.6 million, or $0.28 per basic and diluted share.
  • Revenues for the second quarter of 2021 were $15.1 million, compared to $6.9 million for the same period in 2020.

Colombia - Telecoms, Mobile and Broadband - Statistics and Analyses

Retrieved on: 
Monday, November 19, 2018
Spacecraft, Globalstar, Qualcomm, ETB, Economy of Colombia

The number of lines in service continues to fall steadily, with customers abandoning traditional phones in preference for mobile connectivity.

Key Points: 
  • The number of lines in service continues to fall steadily, with customers abandoning traditional phones in preference for mobile connectivity.
  • The report also covers the fixed and fixed-wireless broadband markets, together with statistics and subscriber forecasts.
  • In addition the report assesses the mobile market, including profiles of the major operators as well as analyses on market developments and emerging technologies.
  • Mvil, Metrotel, Emcali, Virgin Mobile, Mvil xito, Globalstar, BT Colombia, Calipso, Caucatel, Colomsat, Synapsis, Telebucaramanga, Edatel, Empresa de Telecomunicaciones de Santa Fe de Bogot (ETB), Telefnica de Pereira.